Legend Biotech Corp. (LEGN)
18.62
-0.09
(-0.48%)
USD |
NASDAQ |
Oct 09, 16:00
18.62
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Free Cash Flow : -264.16M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -264.16M |
| March 31, 2026 | -251.61M |
| December 31, 2025 | -261.39M |
| September 30, 2025 | -225.04M |
| June 30, 2025 | -332.79M |
| March 31, 2025 | -324.82M |
| December 31, 2024 | -210.32M |
| September 30, 2024 | -238.76M |
| June 30, 2024 | -237.38M |
| March 31, 2024 | -227.23M |
| December 31, 2023 | -384.47M |
| September 30, 2023 | -340.01M |
| Date | Value |
|---|---|
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -249.30M |
| December 31, 2021 | -215.54M |
| September 30, 2021 | -184.95M |
| June 30, 2021 | -204.93M |
| March 31, 2021 | -204.15M |
| December 31, 2020 | -223.21M |
| September 30, 2020 | -227.04M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 12.94B |
| Ionis Pharmaceuticals, Inc. | -567.50M |
| Johnson & Johnson | 22.61B |
| Arbutus Biopharma Corp. | -24.13M |
| Capricor Therapeutics, Inc. | -129.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.87M |
| Cash from Investing (Quarterly) | -120.10M |
| Cash from Financing (Quarterly) | 168.05M |
| Free Cash Flow Per Share (Quarterly) | -0.2141 |
| Free Cash Flow to Equity (Quarterly) | 69.62M |
| Free Cash Flow to Firm (Quarterly) | -38.01M |
| Free Cash Flow Yield | -7.58% |